Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Botox Treatment for Migraine and Chronic Daily Headache in Adolescents
Journal of Neuroscience Nursing, 10/27/09
Chan VW et al. – The authors treated 12 adolescents (aged 14 to 18 years) with Botox injections for migraine and chronic daily headache. Six patients were in long–term treatment and received Botox in the standard "migraine" and "follow–the–pain" patterns every 3 months. Effectiveness was evaluated using pain scales and a standardized quality–of–life survey at baseline and prior to each treatment session. Duration of treatment was 3–29 months. Each patient had 9–63 injections per treatment. All 6 long–term patients reported improvement in headache symptoms, with decreases on pain scales and an average of 33%–75% improvement in quality of life. Two long–term patients had complete relief of headaches between injection series. Four patients had only one series of injections with good results. Two patients had no improvement and refused additional injections. Side effects were mild ptosis, blurred vision, hematoma at neck injection site with tingling in one arm lasting 24 hours, and burning sensations at all injection sites which lasted 1 week.
Related Articles
Tension-Type Headache in Children: The Cinderella of Headache Disorders!
Canadian Journal of Neurological Sciences, 10/26/09
Relevance Score: 94%
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study
Acta Neurologica Scandinavica, 10/06/09
Relevance Score: 93%
Migraine type childhood headache aggravated by sexual abuse: case report
Agri, 10/12/09
Relevance Score: 92%
Botulinum toxin in the treatment of lingual movement disorders
Movement Disorders, 10/06/09
Relevance Score: 90%
Evaluation of Variable-Dose Treatment with a New U.S. Botulinum Toxin Type A (Dysport) for Correction of Moderate to Severe Glabellar Lines: Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Plastic and Reconstructive Surgery, 11/13/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes
Diabetes Care, 11/25/09
Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis
Pediatric Blood & Cancer, 11/25/09
Efficacy of Biofeedback in the Treatment of Migraine and Tension Type Headaches
Pain Physician, 11/25/09
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis
Pediatric Blood & Cancer, 11/25/09
Axenfeld-Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion
Pediatric Blood & Cancer, 11/25/09
Respiratory syncytial virus infections in Central Australia
Journal of Paediatrics and Child Health, 11/25/09
Article Search
Sponsor


See Latest Articles


